Jagsonpal Pharmaceuticals Limited (JAGSNPHARM) — Announcement

📢 Key Event
Company completes 77.21% stake acquisition in Aequitas Healthcare

🔄 What Changed
Acquisition progress updated from proposed 85% to completed 77.21% stake

💡 Investor Takeaway
Shareholders now hold a partial stake in Aequitas through Jagsonpal's acquisition.

Jagsonpal Pharmaceuticals announced completion of acquiring 77.21% equity in Aequitas Healthcare, falling short of the proposed 85% stake, following prior disclosures to exchanges on June 29 and July 7, 2026.

📄 View Original Announcement (PDF)

📊 Stock Analysis — JAGSNPHARM ✨ Ask AI About This

About Jagsonpal Pharmaceuticals Limited (JAGSNPHARM)

Healthcare · Pharmaceuticals & Biotechnology · Listed on NSE

Market Cap: ₹1,384.48 Cr P/E: 32.1

View full JAGSNPHARM stock details →

📡 Get AI alerts when JAGSNPHARM files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track JAGSNPHARM — Free

💡 Ask AI about this filing

"How does this affect JAGSNPHARM margins?" "Compare with last quarter results" "What should investors watch for?"

Ask AI Free →

📊 More JAGSNPHARM filings

See all JAGSNPHARM filings →

🔥 Also filed on 8 July 2026

BAJAJFINSV Bajaj Finserv Limited Annual Report V2RETAIL V2 Retail Limited Annual Report ALLCARGO Allcargo Logistics Limited Announcement GRAPHITE Graphite India Limited Annual Report AJMERA Ajmera Realty & Infra India Limited Announcement GREENPANEL Greenpanel Industries Limited Announcement

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

📡 Get AI alerts when JAGSNPHARM files new disclosures

Track JAGSNPHARM filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track JAGSNPHARM — Free

Free account · 2 AI queries/day